Erratum to "Sirt1 is involved in energy metabolism: The role of chronic ethanol feeding and resveratrol" [Exp. Mol. Path. 85 (2008) 155-159] (DOI:10.1016/j.yexmp.2008.08.002);Sirt1 is involved in energy metabolism: The role of chronic ethanol feeding and resveratrol

Experimental and Molecular Pathology

Volumn 85, Issue 3, 2008, Pages 155-159

  Oliva, Joan ^a   French, Barbara A ^a   Li, Jun ^a   Bardag Gorce, Fawzia ^a   Fu, Paul ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Ethanol; Liver; Naringin; Pathology; Resveratrol; Sirt1

Indexed keywords

ALCOHOL; AURANTIIN; RESVERATROL; SIRTUIN 1;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; LIVER FIBROSIS; LIVER NECROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STEATOSIS;

RATTUS;

EID: 56749173575     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.02.001     Document Type: Erratum

References (40)

1. Bardag-Gorce F., et al. The importance of cycling of blood alcohol levels in the pathogenesis of experimental alcoholic liver disease in rats. Gastroenterology 123 (2002) 325-335
2. Baxter R.A. Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation. J. Cosmet. Dermatol. 7 (2008) 2-7
3. Bouras T., et al. SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J. Biol. Chem. 280 (2005) 10264-10276
4. Das D.K., et al. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs. Exp. Clin. Res. 25 (1999) 115-120
5. Engel N., and Mahlknecht U. Aging and anti-aging: unexpected side effects of everyday medication through sirtuin1 modulation. Int. J. Mol. Med. 21 (2008) 223-232
6. Freedman L., and Merritt A.J. Citrus flavonoid complex: chemical fractionation and biological activity. Science 139 (1963) 344-345
7. French B.A., et al. Microarray analysis of gene expression in the liver during the urinary ethanol cycle in rats fed ethanol intragastrically at a constant rate. Exp. Mol. Pathol. 79 (2005) 87-94
8. Frye R.A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 260 (1999) 273-279
9. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273 (2000) 793-798
10. Fulco M., et al. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12 (2003) 51-62
11. Guarente L., and Picard F. Calorie restriction-the SIR2 connection. Cell 120 (2005) 473-482
12. Hasegawa K., et al. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem. Biophys. Res. Commun. 372 (2008) 51-56
13. Hassan-Khabbar S., et al. Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: a possible strategy in liver surgery. Liver Transpl. 14 (2008) 451-459
14. Inoue T., et al. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 6 (2007) 1011-1018
15. Issemann I., and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 (1990) 645-650
16. Jager S., et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 12017-12022
17. Kobayashi Y., et al. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int. J. Mol. Med. 16 (2005) 237-243
18. Lagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (2006) 1109-1122
19. Lieber C.S., et al. Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1alpha in rats. Biochem. Biophys. Res. Commun. 370 (2008) 44-48
20. Li J., et al. Mechanism of the alcohol cyclic pattern: role of the hypothalamic-pituitary-thyroid axis. Am. J. Physiol. Gastrointest. Liver. Physiol. 279 (2000) G118-125
21. Li J., et al. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology 47 (2008) 613-624
22. Li X., et al. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1alpha transcription coactivator. Nature 447 (2007) 1012-1016
23. Li Y., et al. Bax-inhibiting peptide protects cells from polyglutamine toxicity caused by Ku70 acetylation. Cell Death Differ. 14 (2007) 2058-2067
24. Luo J., et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107 (2001) 137-148
25. Marier J.F., et al. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302 (2002) 369-373
26. Nemoto S., et al. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J. Biol. Chem. 280 (2005) 16456-16460
27. Notas G., et al. Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation. Biochim. Biophys. Acta. 1760 (2006) 1657-1666
28. Plin C., et al. Resveratrol protects against cold ischemia-warm reoxygenation-induced damages to mitochondria and cells in rat liver. Eur. J. Pharmacol. 528 (2005) 162-168
29. Puigserver P., et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92 (1998) 829-839
30. Puigserver P., et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol. Cell 8 (2001) 971-982
31. Ray P.S., et al. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic. Biol. Med. 27 (1999) 160-169
32. Rodgers J.T., et al. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. 582 (2008) 46-53
33. Roy S.K., and S L. Resveratrol. Pennington Nutrition Series (2005) 7
34. Shang J., et al. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta. Pharmacol. Sin. 29 (2008) 698-706
35. Vaziri H., et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107 (2001) 149-159
36. Yeung F., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23 (2004) 2369-2380
37. You M., et al. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am. J. Physiol. Gastrointest Liver Physiol. 294 (2008) G892-898
38. Yu C., et al. Human, rat, and mouse metabolism of resveratrol. Pharm. Res. 19 (2002) 1907-1914
39. Yu J., et al. Lipoprotein lipase activator no-1886 ameliorates the severity of dietary steatohepatitis in mice. Gastroenterology 131 (2006) A-825
40. Zhao X., et al. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell Biol. 25 (2005) 8456-8464